Publications by authors named "Josh Veasy"

Claim this Profile
M
Model-Based Benefit/Risk Analysis for the Copanlisib Intermittent Dosing Regimen.
Peter N Morcos, Jonathan Moss, Josh Veasy, Florian Hiemeyer, Barrett H Childs

Clin Pharmacol Therยท May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis